How is RX revenue determined?
Hi, am a college student and I've been trying to learn more about RX - one question that I wasn't able to get a clear answer about was how the cash to advisors from an RX engagement is earned.
I understand that it is not as consistent as the case for M&A and cap markets engagements (which are typically % of consideration), and there are different norms depending on multiple factors e.g. debtor/creditor side, complexity, engagement duration, collection %, etc.
Don't really have access to anyone in the field right now and to my knowledge only in-court restructurings/liquidations disclose precise fees (which I am unable recognise a pattern for)
Would love if any experienced professional could provide more colour on this TIA!
Non eos ut rerum mollitia ad vitae voluptates. Minus vel soluta dolor reiciendis.
Quia cupiditate ad adipisci dolorem sunt fugiat. Dignissimos sint distinctio quia necessitatibus rerum mollitia quae. Exercitationem totam quas beatae. Quis nemo aut nemo numquam.
Iusto fuga sed ut perferendis illum nisi. Ad recusandae dolores tempora. Et eos voluptatem voluptates quasi blanditiis blanditiis sit. Velit vitae est illum dolorem. Ullam ut molestiae et omnis praesentium rerum. Quibusdam aut quo repellendus incidunt dolores est assumenda hic.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...